Moderate or Severe Submental Fullness

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Moderate or Severe Submental Fullness trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

RecruitingPhase 1

NCT06756490

A Phase I Study of HY-2003 in the Subjects With Excessive Submental Fat Accumulation

The main purpose of this study is to evaluate the safety of HY-2003 in subjects with moderate to severe submental fat accumulation at different doses and dosing…

China30 participantsStarted 2024-12-26

Treatment: HY-2003 (10 mg/ml), BELKYRA and placebo, HY-2003 (5 mg/ml) and placebo

All recent trials (13 shown)

CompletedPhase 2

NCT05266729

Determine the Dosing Interval and Optimal Dose of AYP-101 for the Reduction of Submental Fat in Chin Area

To determine the dosing interval, optimal dose, evaluate safety, and efficacy of AYP-101 S.C injection for the reduction of Submental Fat (SMF).

South Korea96 participantsStarted 2022-03-02

Treatment: Polyene Phosphatidylcholine, Placebo

CompletedPhase 2

NCT03982225

Evaluate the Efficacy and Safety of Polyene Phosphatidylcholine Injection (AYP-101) for the Reduction of Submental Fat

Phase 2 trial to evaluate the safety and potential efficacy of three concentration of polyene phosphatidylcholine injection (AYP-101) compared to placebo for th…

South Korea143 participantsStarted 2019-07-01

Treatment: Polyene phosphatidylcholine injection, Placebo

Moderate or Severe Submental Fullness

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

A Phase I Study of HY-2003 in the Subjects With Excessive Submental Fat Accumulation

All recent trials (13 shown)

Determine the Dosing Interval and Optimal Dose of AYP-101 for the Reduction of Submental Fat in Chin Area

Evaluate the Efficacy and Safety of Polyene Phosphatidylcholine Injection (AYP-101) for the Reduction of Submental Fat

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

A Phase I Study of HY-2003 in the Subjects With Excessive Submental Fat Accumulation

All recent trials (13 shown)

Determine the Dosing Interval and Optimal Dose of AYP-101 for the Reduction of Submental Fat in Chin Area

Evaluate the Efficacy and Safety of Polyene Phosphatidylcholine Injection (AYP-101) for the Reduction of Submental Fat

Safety Study of ATX-101 (Deoxycholic Acid) in Subjects With Mild or Extreme Fullness of Submental Fat

Open-Label Study of Deoxycholic Acid for the Reduction of Localized Subcutaneous Fat in the Submental Area

Patient Experience Study of Deoxycholic Acid Injection

Phase 2 Study of Deoxycholic Acid Injection (ATX-101) for the Reduction of Submental Fat

Evaluation of Safety and Efficacy of Deoxycholic Acid Injection (ATX-101) in the Reduction of Submental Fat

Phase 1-2 Study of Deoxycholic Acid Injection (ATX-101) for the Reduction of Submental Fat

Phase 3 Study of Deoxycholic Acid Injection (ATX-101) Versus Placebo for the Reduction of Localized Subcutaneous Fat in…

Deoxycholic Acid Injection Submental Fat (SMF) Magnetic Resonance Imaging (MRI) and Subject-reported Outcome Measures St…

Phase 3 Study of Deoxycholic Acid Injection (ATX-101) Versus Placebo for the Reduction of Localized Subcutaneous Fat in…

Evaluation of Safety and Efficacy of Deoxycholic Acid Injection (ATX-101) in the Reduction of Submental Fat